دانلود کتاب Prolactinomas, An interdisciplinary approach: Proceedings of the International Symposium on Prolactinomas Graz (Austria), April 29 – May 2, 1984

فهرست مطالب :

I Morphology\nStructure and ultrastructure of prolactinomas\nProlactinomas and mixed adenomas with prolactin cells: an immunohistochemical study of the subcellular localization of hormones\nImmunocytochemical, chemical and nuclear-DNA studies of pituitary tumours\nHyperplasia of prolactin pituitary cells with or without microadenoma\nHormone-secretion in cell culture of microprolactinomas, periadenomatous tissue and capsules\nImmunocytochemical ultrastructural and culture characteristics of prolactin-secreting pituitary adenomas\nImmunohistochemical hormone determinations in pituitary adenomas in comparison with endocrinological findings in vivo\nNew immunocytochemical observations in prolactinomas\nProblematic divergencies between clinical and immunocytochemical findings in prolactinomas\nNecrosis of prolactinoma cells after bromocriptine treatment\nSpontaneous pituitary lesions and plasma prolactin levels in rats\nII Radiology\nCT-findings in pituitary adenomas\nComparative study of normal subjects and cases with microadenoma on high-resolution computed tomography\nIII Endocrinological and clinical aspects\nActions of dopamine receptor agonists at the pituitary level\nDopamine and prolactinomas\nRhythmometric study of the circadian profile of plasma prolactin in patients with prolactinoma or empty sella syndrome\nProlactin responses to thyrotropin-releasing hormone, metoclopramide and insulin- induced hypoglycaemia in hyperprolactinaemic and normoprolactinaemic patients\nEvidence for functional impairment of growth hormone secretion in prolactinoma\nTHS response to dopamine receptor blockade in women with PRL-secreting microadenoma: long lasting effect of surgical removal\nProlactin and TSH responses to TRH and domperidone in delayed puberty\nAnterior pituitary function in patients with prolactinomas\nPituitary adenomas with hyperprolactinaemia in males\nProlactinoma in multiple endocrine neoplasia type I\nRecurrence of hyperprolactinaemia detected in long-term follow-up of surgically normalised microprolactinomas\nImpairment of pituitary hormone secretion in patients with prolactinoma\nIV Surgical treatment\nThe recurrence of pituitary adenoma — a management challenge\nTranssphenoidal operations for prolactinomas\nProlactinomas: surgical results in 96 cases\nEffect of transsphenoidal surgery on pituitary function\nTranssphenoidal microsurgical treatment of 77 prolactinomas\nReview of 56 prolactin-secreting pituitary adenomas\nThe effect of transsphenoidal selective microadenomectomy on patients with prolactinomas\nSurgical results and long-term follow-up in female and male prolactinomas\nOtoliquorrhoea in large prolactinomas. Pathomechanism and surgical management\nInvasive prolactinomas in adolescents\nResidual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas\nLong-term follow-up of prolactinomas. Clinical and morphologic correlation\nClinicopathological and neurosurgical comparative analysis of operated recurrent prolactinomas and non-secreting chromophobe pituitary adenomas\nV Pharmacotherapy\nNew aspects of medical treatment of prolactinomas\nConservative management of prolactinoma\nEffect of bromocriptine therapy on large prolactinomas\nMacroprolactinomas in male patients: efficiency of treatment with a new dopaminergic drug (CU 32-085-Sandoz), tumor calcification and relative significance of preoperative tumour volume regression as estimated by CT-scan\nEvidence for spontaneous tumour shrinkage in a 45-year-old patient with a 20-year history of untreated microprolactinoma\nThe influence of various forms of treatment on serum levels of prolactin, growth hormone and insulin-like growth factors I and II in patients with hyperprolactinaemia and acromegaly\nPersisting partial suppression of growth hormone excess in acromegaly after long-term treatment with bromocriptine\nMedical and surgical treatment of micro- and macroprolactinomas: seven years followup of 65 cases\nVI Aspects of gynecology and obstetrics\nManagement of prolactinomas in pregnancy\nLong-term follow-up of hyperprolactinaemia in women\nProphylactic bromocriptine treatment during pregnancy of women with macroprolactinomas: report of thirteen pregnancies\nNatural regression after pregnancy of a CT visualized microprolactinoma\nProlactin levels and ovarian function after surgical treatment of prolactinomas\nPregnancies after treatment of prolactinomas — course and complications\nPsychosomatic findings in patients with elevated prolactin\nList of contributors\nAuthors’ index\nSubject index